DCAT Week 2026 — Room #1712 at The Lotte New York Palace
MedPharm Announces Successful U.S. FDA Inspection of its CGMP Commercial Manufacturing Facility In Durham, North Carolina
DURHAM, N.C., January 7, 2026 – MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, today announced that its topical drug product manufacturing facility in Durham has successfully completed a U.S. Food and Drug Administration (FDA) inspection for commercial manufacture of drug products.
MedPharm will be at Drug Delivery to the Lungs 2025 – Booth #180
MedPharm’s Partner Heparin Therapeutics Publishes Landmark Study on Inhaled UFH
Durham, NC, October 9, 2025 – MedPharm, a global leader in topical and transdermal contract drug development and manufacturing, congratulates its partner, Heparin Therapeutics, on the recent publication of their pivotal clinical findings in a Lancet Group journal.
